Viehbacher Christopher has filed 15 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 38015 shares of BIOGEN INC. ($BIIB) on February 13, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | A | Restricted Stock Unit | 38015 | $0.00 | 38,015.0000 | 170,500,000 | 9999.99% | 0.02% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | M | Common Stock | 9008 | $0.00 | 25,451.0000 | 170,500,000 | 54.78% | 0.01% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | F | Common Stock | 4356 | $201.18 | 21,095.0000 | 170,500,000 | 17.12% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | M | Common Stock | 15453 | $0.00 | 36,548.0000 | 170,500,000 | 73.25% | 0.01% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | F | Common Stock | 6624 | $201.18 | 29,924.0000 | 170,500,000 | 18.12% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | M | Restricted Stock Unit | 15453 | $0.00 | 30,907.0000 | 170,500,000 | 33.33% | 0.01% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | M | Restricted Stock Unit | 9008 | $0.00 | 9,009.0000 | 170,500,000 | 50.00% | 0.01% |
| Dec. 1, 2025 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | M | Restricted Stock Unit | 7040 | $0.00 | 0.0000 | 170,500,000 | 100.00% | 0.00% |
| Dec. 1, 2025 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | M | Common Stock | 7040 | $0.00 | 19,847.0000 | 170,500,000 | 54.97% | 0.00% |
| Dec. 1, 2025 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | F | Common Stock | 3404 | $177.78 | 16,443.0000 | 170,500,000 | 17.15% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | M | Common Stock | 9008 | $0.00 | 16,008.0000 | 169,500,000 | 128.69% | 0.01% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | M | Restricted Stock Unit | 9008 | $0.00 | 18,017.0000 | 169,500,000 | 33.33% | 0.01% |
| Feb. 6, 2025 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | A | Restricted Stock Unit | 46360 | $0.00 | 46,360.0000 | 169,500,000 | 9999.99% | 0.03% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | F | Common Stock | 3201 | $141.35 | 12,807.0000 | 169,500,000 | 20.00% | 0.00% |
| Feb. 7, 2024 | BIOGEN INC. | $BIIB | Viehbacher Christopher | President and CEO | A | Restricted Stock Unit | 27025 | $0.00 | 27,025.0000 | 168,700,000 | 9999.99% | 0.02% |